Kang Z. Qin
16 Jiangsu Road
Qingdao, 266005, China
Qingdao, 266005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Acute promyelocytic leukemia peripheral nerve infiltration: a case report
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 07, 2025
In situ Hg2+ improved the peroxidase-like activity and triggered "ON" the oxidase-like activity of yolk-shell Co3S4 microspheres for the detection of Hg2.
Journal: The Analyst
Published: December 22, 2023
Correction to: Characterization of the microbial community and prediction of metabolic functions in an anaerobic/oxic system with magnetic micropolystyrene as a biocarrier.
Journal: Environmental science and pollution research international
Published: October 04, 2023
Characterization of the microbial community and prediction of metabolic functions in an anaerobic/oxic system with magnetic micropolystyrene as a biocarrier.
Journal: Environmental science and pollution research international
Published: April 13, 2023
Enhanced bio-affinity of magnetic QD-P(St-GMA)@Fe3O4 micro-particles via surface-quaternized modification.
Journal: Environmental science and pollution research international
Published: January 16, 2023
The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 15, 2020
Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 25, 2019
Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Journal: Thoracic cancer
Published: October 15, 2019
Survival-associated alternative splicing signatures in non-small cell lung cancer.
Journal: Aging
Published: July 25, 2019
Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Journal: BMC cancer
Published: July 24, 2019
Effect and biomarker of Nivolumab for non-small-cell lung cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 20, 2019
Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC.
Journal: Cancer management and research
Published: January 14, 2019
Last Updated: 09/26/2026